Top compounds associated with response to ME3


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.12 0.001
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.12 0.001
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA paclitaxel FIMM pan-cancer AAC 0.37 0.003
mRNA BMS-345541 CTRPv2 pan-cancer AAC -0.12 0.003
mRNA VX-11e GDSC1000 pan-cancer AAC 0.11 0.003
Download CSV